Ô¨Åcient indication for the
use of these agents in most patients, who are considered to
be at high risk for cardiovascular complications and stroke.
In a systematic review236 of the effect of antiplatelet
treatment compared with placebo on bypass graft patency,
patients receiving antiplatelet therapy had improved patency
at 1 year (OR, 0.62; 95% CI, 0.43-0.86). When venous and